Opportunity
Simpler Grants.gov #HT942526BCRPBTA3
Army Solicits Proposals for FY26 Breast Cancer Breakthrough Research Award
Buyer
Dept. of the Army -- USAMRAA
Posted
May 04, 2026
Respond By
September 30, 2026
Identifier
HT942526BCRPBTA3
NAICS
541715
The Dept. of the Army is inviting research proposals for the FY26 Breast Cancer Research Program (BCRP) Breakthrough Award Level 3. - Government Buyer: - Dept. of the Army, US Army Medical Research Acquisition Activity (USAMRAA) - Program Details: - Part of the Congressionally Directed Medical Research Programs (CDMRP) - Seeks high-impact research with potential for breakthroughs in breast cancer - Open to all eligible applicants (unrestricted) - Requirements: - Proposals must address at least one FY26 BCRP overarching challenge or justify an exception - Research teams must include two or more breast cancer consumer advocates - Option to include small-scale clinical trials - Supports either a single Principal Investigator or two partnering PIs - Funding and Awards: - Total available funding: approximately $12.6 million - Up to two awards expected - Maximum period of performance: four years - No cost sharing or matching required - Notable: - No specific OEMs or vendors are mentioned, as this is a research grant solicitation, not a product procurement
Description
The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award Level 3 supports promising research with high potential to lead to breakthroughs in breast cancer. Applications must address at least one of the FY26 BCRP overarching challenges or provide justification for exception, aiming for major impact. This award mechanism allows for small-scale clinical trials and requires the research team to include two or more breast cancer consumer advocates. It supports major stages of research leading to clinical application, with options for a single Principal Investigator or two partnering PIs.